Korean researchers unlock genetic clues to lupus
In a major leap forward for autoimmune disease research, South Korean researchers have developed a high-resolution genetic analysis tool that can precisely decode the complex immune-related gene cluster linked to lupus. This discovery not only deepens understanding of how lupus begins but also could lead to customized treatments tailored to individual genetic profiles, they say.
'There are two major breakthroughs here,' said Professor Bae Sang-cheol of Hanyang University Hospital for Rheumatic Diseases, who led the study, in a phone interview with The Korea Herald.
'First, the immune-related genes located in the MHC region on chromosome 6 are extremely complex, making them difficult to analyze. With this new tool, we can now accurately and easily analyze this region. This creates a foundational infrastructure that could be used to uncover genetic causes of not only lupus, but also other autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease.'
The study, conducted in collaboration with Professor Kim Kwangwoo at Kyung Hee University and the National Institute of Health's genome research department, focused on a section of our DNA called the MHC region, short for Major Histocompatibility Complex.
This part of our genetic code plays a key role in controlling the immune system. It includes important genes like HLA and C4, both of which have been suspected of having links to autoimmune diseases, Bae explained.
Lupus, also known as systemic lupus erythematosus, is a disease where the body's immune system starts attacking healthy cells and organs.
It can affect the skin, joints, kidneys, brain and more. Scientists have long believed that certain genes may increase the likelihood of developing lupus in some individuals, but determining which genes are involved has been a major challenge, as there are as many as 200 genes discovered to have an impact — until now.
The MHC imputation reference panel developed by the research will enable the analysis of a tricky part of the genome in more detail, which is an important step toward understanding lupus on a genetic level. This will give a clearer picture of why some people develop lupus and how their immune system breaks down.
The second major advancement, Bae explained, is in precision medicine.
"Unlike other genetic disorders caused by one or two mutations, lupus is driven by a combination of many genetic factors and influenced by environmental triggers, which makes identifying the cause extremely difficult,' he said.
'But now, by understanding these complex combinations, we can move toward personalized treatment. For example, if we identify that a patient's disease is linked to the C4 gene — one of the strongest known genetic risk factors — we can choose a drug that specifically targets that mechanism. This opens the door not just to more effective therapies but also to developing new drugs.'
What sets this tool apart is not only its precision but also its cultural relevance.
'Until now, most panels like this were built using data from people in the US,' Bae said. 'That meant they didn't include East Asian-specific genetic variations, which reduced accuracy for Koreans and other Asians. Now, this tool dramatically improves precision for our population. It's meaningful that Korea and other East Asian countries are now leading this field.'
The new panel will be made publicly available through Korea's national CODA system, allowing researchers worldwide to access it for studies on lupus, other autoimmune disorders, infectious diseases and chronic inflammatory illnesses.
'This is just the beginning,' Bae said. 'Autoimmune diseases are even more complex than cancer because the genetic combinations vary so much from person to person. But if we can sort people by their genetic profile and match them with the right drugs, it could open doors to more precise treatments for everyone."
The study was published in Annals of the Rheumatic Diseases, one of the most prestigious international journals in the field.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
![[Editorial] Korea's academic exodus](/_next/image?url=https%3A%2F%2Fall-logos-bucket.s3.amazonaws.com%2Fkoreaherald.com.png&w=48&q=75){kind=small}
Korea Herald
a day ago
- Korea Herald
[Editorial] Korea's academic exodus
As professors head overseas, South Korea's global academic standing comes under strain At Seoul National University, long regarded as the pinnacle of South Korea's higher education system, an unsettling pattern has emerged. Over the past four years, 56 professors have left for academic posts overseas, a quiet but steady migration to institutions offering not only higher salaries but also more generous research funding and fewer bureaucratic hurdles. The symbolism is hard to miss: Even South Korea's most prestigious university struggles to retain talent in an era when intellectual capital moves easily across borders. The numbers point to a deeper problem. Most of the departing professors headed to the United States, with others choosing academic positions in Hong Kong, Singapore and elsewhere. The exodus isn't limited to Seoul National University. The nation's top science and technology institutes — KAIST, GIST, DGIST and UNIST — have lost 119 professors over the same period. While some scholars moved to vacancies at Seoul National University, many others left the country altogether. The causes aren't new, nor are they difficult to diagnose. South Korean universities have long been constrained by structural barriers that leave them uncompetitive in the global academic market. Faculty pay, tied to rigid seniority-based systems and frozen tuition rates, has remained stagnant for more than a decade. The government's policy of keeping tuition low (once seen as a way to expand access) has instead restricted resources for institutions struggling to retain their best staff. Abroad, professors can earn three to four times more, but the draw isn't purely financial. Top universities overseas offer superior research facilities, larger budgets and streamlined administrations. These advantages are especially significant for scholars pursuing cutting-edge work in fields like artificial intelligence, semiconductors, biotechnology and economics. But this brain drain is about more than money. It points to a deeper institutional flaw. Political interference, particularly in setting research agendas and allocating funding, undermines academic autonomy. In South Korea, government transitions often bring abrupt shifts in research priorities and personnel, making long-term planning difficult. Professors have long voiced frustration with this volatile environment, which leaves little room for independent scholarship. The loss of academic talent is becoming self-perpetuating. Professors at regional institutions leave for Seoul; those at Seoul National University increasingly look overseas. The resulting vacuum weakens not only individual universities but also the broader academic ecosystem underpinning the country's research and innovation. The consequences are serious. As faculty exit, research capacity diminishes, graduate programs decline and national competitiveness suffers. International rankings already show South Korean universities slipping, with only a few maintaining a presence among the world's elite. The long-term risk is that South Korea could fall behind in critical fields vital for economic growth and national security. Yet the government's response appears out of step with the scale of the problem. President Lee Jae Myung's pledge to 'create 10 Seoul National Universities' by elevating nine regional universities may misread the crisis. Adding more institutions does little to address the core issue: Retaining and attracting world-class talent. Without serious reform, even Seoul National University may struggle to maintain its standing. What's needed isn't lofty slogans but structural change. Performance-based pay, already under discussion at Seoul National University, is a start, but not enough. Broader reforms must include competitive salaries, greater research autonomy and less political micromanagement. Efforts to support weaker institutions should avoid a one-size-fits-all approach. Targeted, merit-based investments offer a more effective, sustainable path. Above all, South Korea must rethink how it values academic work. In an era when AI and advanced technologies drive global competition, retaining and attracting researchers is a matter of national strategy. The goal should not merely be to stem the brain drain but to build an academic ecosystem that draws homegrown talent back — and invites the world's best to come.
Korea Herald
2 days ago
- Korea Herald
India marks Yoga Day in Seoul
The Indian Embassy in Seoul celebrated the 11th International Day of Yoga on June 21. The United Nations General Assembly designated June 21 as the International Day of Yoga in 2014, with the support of 175 member states. This year's theme, 'Yoga for One Earth, One Health,' emphasized the interconnectedness between personal well-being and the health of the planet. According to the embassy, yoga's origins trace back approximately 3,000 years, with its principles codified in the "Yoga Sutras" by Hindu sage Patanjali around 200 BC. Patanjali, known as the father of modern yoga, wrote the "Yoga Sutras," a collection of Sanskrit aphorisms on the theory and practices of ancient yoga. Speaking at the event, Indian Ambassador to Korea Amit Kumar said that Yoga teaches us that we are not isolated individuals but integral parts of nature. The health of every entity on Earth is interconnected. Yoga transitions us from "Me to We," Kumar said, echoing the words of Prime Minister Narendra Modi. Sharing a press release with The Korea Herald after the event, the embassy highlighted partnerships with Wonkwang Digital University and Busan University of Foreign Studies, which offer advanced academic programs in yoga and wellness, and degrees up to doctoral level. The event was attended by more than 700 yoga enthusiasts, comprising Koreans, embassy officials and members of the Indian community and diplomatic corps. sanjaykumar@
Korea Herald
2 days ago
- Korea Herald
Korean researchers unlock genetic clues to lupus
High-resolution genetic analysis opens door to personalized treatments In a major leap forward for autoimmune disease research, South Korean researchers have developed a high-resolution genetic analysis tool that can precisely decode the complex immune-related gene cluster linked to lupus. This discovery not only deepens understanding of how lupus begins but also could lead to customized treatments tailored to individual genetic profiles, they say. 'There are two major breakthroughs here,' said Professor Bae Sang-cheol of Hanyang University Hospital for Rheumatic Diseases, who led the study, in a phone interview with The Korea Herald. 'First, the immune-related genes located in the MHC region on chromosome 6 are extremely complex, making them difficult to analyze. With this new tool, we can now accurately and easily analyze this region. This creates a foundational infrastructure that could be used to uncover genetic causes of not only lupus, but also other autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease.' The study, conducted in collaboration with Professor Kim Kwangwoo at Kyung Hee University and the National Institute of Health's genome research department, focused on a section of our DNA called the MHC region, short for Major Histocompatibility Complex. This part of our genetic code plays a key role in controlling the immune system. It includes important genes like HLA and C4, both of which have been suspected of having links to autoimmune diseases, Bae explained. Lupus, also known as systemic lupus erythematosus, is a disease where the body's immune system starts attacking healthy cells and organs. It can affect the skin, joints, kidneys, brain and more. Scientists have long believed that certain genes may increase the likelihood of developing lupus in some individuals, but determining which genes are involved has been a major challenge, as there are as many as 200 genes discovered to have an impact — until now. The MHC imputation reference panel developed by the research will enable the analysis of a tricky part of the genome in more detail, which is an important step toward understanding lupus on a genetic level. This will give a clearer picture of why some people develop lupus and how their immune system breaks down. The second major advancement, Bae explained, is in precision medicine. "Unlike other genetic disorders caused by one or two mutations, lupus is driven by a combination of many genetic factors and influenced by environmental triggers, which makes identifying the cause extremely difficult,' he said. 'But now, by understanding these complex combinations, we can move toward personalized treatment. For example, if we identify that a patient's disease is linked to the C4 gene — one of the strongest known genetic risk factors — we can choose a drug that specifically targets that mechanism. This opens the door not just to more effective therapies but also to developing new drugs.' What sets this tool apart is not only its precision but also its cultural relevance. 'Until now, most panels like this were built using data from people in the US,' Bae said. 'That meant they didn't include East Asian-specific genetic variations, which reduced accuracy for Koreans and other Asians. Now, this tool dramatically improves precision for our population. It's meaningful that Korea and other East Asian countries are now leading this field.' The new panel will be made publicly available through Korea's national CODA system, allowing researchers worldwide to access it for studies on lupus, other autoimmune disorders, infectious diseases and chronic inflammatory illnesses. 'This is just the beginning,' Bae said. 'Autoimmune diseases are even more complex than cancer because the genetic combinations vary so much from person to person. But if we can sort people by their genetic profile and match them with the right drugs, it could open doors to more precise treatments for everyone." The study was published in Annals of the Rheumatic Diseases, one of the most prestigious international journals in the field.
